Insider Trading:: Victrex plc (LON:VCT) Insider Sold 1,807 Shares of Shares

Insider Trading:: Victrex plc (LON:VCT) Insider Sold 1,807 Shares of Shares

Victrex plc (LON:VCT) insider Timothy (Tim) J. Cooper sold 1,807 shares of the stock in a transaction that occurred on Friday, December 14th. The stock was sold at an average price of GBX 2,228 ($29.11), for a total value of £40,259.96 ($52,606.77).

Shares of VCT traded down GBX 16 ($0.21) during trading hours on Friday, hitting GBX 2,382 ($31.13). The stock had a trading volume of 219,258 shares, compared to its average volume of 274,177. Victrex plc has a 12-month low of GBX 1,826 ($23.86) and a 12-month high of GBX 2,772 ($36.22).

The business also recently declared a dividend, which will be paid on Friday, February 22nd. Stockholders of record on Thursday, January 31st will be given a GBX 128.82 ($1.68) dividend. This represents a dividend yield of 5.46%. The ex-dividend date is Thursday, January 31st. This is a positive change from Victrex’s previous dividend of $13.42.

A number of equities research analysts recently weighed in on VCT shares. UBS Group restated a “buy” rating and issued a GBX 3,200 ($41.81) price target (down previously from GBX 3,600 ($47.04)) on shares of Victrex in a report on Thursday, December 6th. Morgan Stanley cut Victrex to an “underweight” rating and lowered their target price for the company from GBX 2,500 ($32.67) to GBX 2,300 ($30.05) in a report on Friday, October 12th. HSBC reiterated a “hold” rating on shares of Victrex in a report on Tuesday. Liberum Capital reiterated a “buy” rating on shares of Victrex in a report on Tuesday, October 16th. Finally, Peel Hunt reiterated an “add” rating on shares of Victrex in a report on Friday, January 4th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. Victrex currently has a consensus rating of “Hold” and a consensus price target of GBX 2,665.56 ($34.83).

About Victrex

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.

Further Reading: Tariff

Related posts

Leave a Comment